Mod GRF and GHRP-2 is a research peptide blend combining GHRH and ghrelin receptor agonists for experimental GH axis modeling. Mod GRF (CJC-1295 no DAC) engages GHRH receptor–driven cAMP/PKA signaling, while GHRP-2 binds GHS-R1a, activating Gq/11-mediated calcium release. This blend is applied in preclinical studies to analyze peptide synergy, pituitary signaling, and endocrine regulation mechanisms.
For research use only. Not for human consumption.
References:
Bowers CY et al., Endocrinology, 1990 126(2):1165–1171
Teichman SL et al., J Clin Endocrinol Metab, 2006 91(2):479–487
Kojima M et al., Nature, 1999 402(6762):656–660
New
Mod GRF, GHRP-6 10mg (Blend)
$95.00
Mod GRF and GHRP-2 is a research peptide blend combining GHRH and ghrelin receptor agonists for experimental GH axis modeling. Mod GRF (CJC-1295 no DAC) engages GHRH receptor–driven cAMP/PKA signaling, while GHRP-2 binds GHS-R1a, activating Gq/11-mediated calcium release. This blend is applied in preclinical studies to analyze peptide synergy, pituitary signaling, and endocrine regulation mechanisms.
Description
Shipping & Delivery
Related products
AOD9604 6mg
AOD9604 is a modified version of the hGH fragment 176-191 peptide (contains a di-sulfide bridge) and thus a derivative of human growth hormone (hGH). Originally developed as a lipolytic (fat burning) compound, AOD9604 has shown benefit in studies of heart disease, osteoarthritis/cartilage repair, and metabolic syndrome. AOD9604 stimulates lipolysis (the breakdown or destruction of fat) and inhibits lipogenesis in animal studies.
BPC-157 10mg
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. BPC-157 15mg
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. 
TB-500 (Thymosin Beta-4) (43aa) (2mg x 10 Vials = 20mg)
TB-500 (Thymosin Beta-4) is a 43 amino acid peptide sequence. In animal models, Thymosin Beta-4 has been shown to improve blood vessel growth, regulate wound healing, decrease inflammation, and reduce oxidative damage in the heart and central nervous system. Thymosin-beta-4 has a role in protection, tissue repair, regeneration and remodeling of injured or damaged tissues. It is also of active interest in anti-aging research.
Reviews
There are no reviews yet.